基本情報
- 所属
- 自治医科大学 医学部外科学講座 消化器一般移植外科学部門 助教
- 学位
- 医学博士(2013年3月 自治医科大学)
- J-GLOBAL ID
- 202201020200507500
- researchmap会員ID
- R000043667
研究分野
1受賞
2-
2023年3月
-
2011年3月
論文
33-
Scientific Reports 14(1) 2024年2月26日Abstract Intestinal adaptation does not necessarily recover absorptive capacity in short bowel syndrome (SBS), sometimes resulting in intestinal failure-associated liver disease (IFALD). Additionally, its therapeutic options remain limited. Polyamines (spermidine and spermine) are known as one of the autophagy inducers and play important roles in promoting the weaning process; however, their impact on intestinal adaptation is unknown. The aim of this study was to investigate the impact of polyamines ingestion on adaptation and hepatic lipid metabolism in SBS. We performed resection of two-thirds of the small intestine in male Lewis rats as an SBS model. They were allocated into three groups and fed different polyamine content diets (0%, 0.01%, 0.1%) for 30 days. Polyamines were confirmed to distribute to remnant intestine, whole blood, and liver. Villous height and number of Ki-67-positive cells in the crypt area increased with the high polyamine diet. Polyamines increased secretory IgA and mucin content in feces, and enhanced tissue Claudin-3 expression. In contrast, polyamines augmented albumin synthesis, mitochondrial DNA copy number, and ATP storage in the liver. Moreover, polyamines promoted autophagy flux and activated AMP-activated protein kinase with suppression of lipogenic gene expression. Polyamines ingestion may provide a new therapeutic option for SBS with IFALD.
-
Transplant international : official journal of the European Society for Organ Transplantation 37 11336-11336 2024年Segmental grafts from living donors have advantages over grafts from deceased donors when used for small intestine transplantation. However, storage time for small intestine grafts can be extremely short and optimal graft preservation conditions for short-term storage remain undetermined. Secreted factors from mesenchymal stem cells (MSCs) that allow direct activation of preserved small intestine grafts. Freshly excised Luc-Tg LEW rat tissues were incubated in preservation solutions containing MSC-conditioned medium (MSC-CM). Preserved Luc-Tg rat-derived grafts were then transplanted to wild-type recipients, after which survival, injury score, and tight junction protein expression were examined. Luminance for each graft was determined using in vivo imaging. The findings indicated that 30-100 and 3-10 kDa fractions of MSC-CM have superior activating effects for small intestine preservation. Expression of the tight-junction proteins claudin-3, and zonula occludens-1 preserved for 24 h in University of Wisconsin (UW) solution containing MSC-CM with 50-100 kDa, as shown by immunostaining, also indicated effectiveness. Reflecting the improved graft preservation, MSC-CM preloading of grafts increased survival rate from 0% to 87%. This is the first report of successful transplantation of small intestine grafts preserved for more than 24 h using a rodent model to evaluate graft preservation conditions that mimic clinical conditions.
-
Mesenchymal Stem Cells Secretions Enhanced ATP Generation on Isolated Islets during Transplantation.Islets 14(1) 69-81 2022年12月31日The success of islet transplantation in both basic research and clinical settings has proven that cell therapy has the potential to cure diabetes. Islets intended for transplantation are inevitably subjected to damage from a number of sources, including ischemic injury during removal and delivery of the donor pancreas, enzymatic digestion during islet isolation, and reperfusion injury after transplantation in the recipient. Here, we found that protein factors secreted by porcine adipose-tissue mesenchymal stem cells (AT-MSCs) were capable of activating preserved porcine islets. A conditioned medium was prepared from the supernatant obtained by culturing porcine AT-MSCs for 2 days in serum-free medium. Islets were preserved at 4°C in University of Wisconsin solution during transportation and then incubated at 37°C in RPMI-1620 medium with fractions of various molecular weights prepared from the conditioned medium. After treatment with certain fractions of the AT-MSC secretions, the intracellular ATP levels of the activated islets had increased to over 160% of their initial values after 4 days of incubation. Our novel system may be able to restore the condition of isolated islets after transportation or preservation and may help to improve the long-term outcome of islet transplantation.Abbreviations: AT-MSC, adipose-tissue mesenchymal stem cell; Cas-3, caspase-3; DAPI, 4,6-diamidino-2-phenylindole; DTZ, dithizone; ES cell, embryonic stem cell; FITC, fluorescein isothiocyanate; IEQ, islet equivalent; INS, insulin; iPS cell, induced pluripotent stem cell; Luc-Tg rat, luciferase-transgenic rat; PCNA, proliferating cell nuclear antigen; PDX1, pancreatic and duodenal homeobox protein-1; UW, University of Wisconsin; ZO1, zona occludens 1.
-
Amino acids 53(11) 1695-1703 2021年11月Polyamines are important to the survival and activation of organs and tissues via a homeostatic cell-metabolic process, and the polyamine content in cytoplasm decreases with aging. Decreases in cellular polyamine have been known to augment mutagenesis and cell death. Thus, supplementary polyamine in food is important to the prevention of aging. Here we show the anti-aging effects of oral intake of polyamine using luciferase-transgenic rats. Healthy rats, 10-12 weeks old, were given foods containing 0.01% and 0.1% (w/w) of polyamine, as compared a control food without polyamine, for 4 weeks. Using a bioimaging system, the photon intensities seen in the whole bodies and livers of rats consuming 0.1% of polyamine in food were stronger than those in rats consuming 0.01% and 0% of polyamine. However, there were no differences between groups in other characteristics, such as liver damage and body weight. In conclusion, we found that polyamine intake can activate cells throughout the whole body, providing an anti-aging effect.
-
Japanese Journal of Gastroenterological Surgery 54(8) 538-547 2021年A 48-year-old man underwent skin grafting from the left inguinal region to the left forearm one month previously. He noticed abdominal discomfort after discharge and was admitted to another hospital because of progression of abdominal pain and a decreased level of consciousness. An enhanced CT scan revealed extensive portal venous thrombosis. Lower gastrointestinal bleeding developed the following day, and he was transferred to our hospital and diagnosed with superior mesenteric venous thrombosis. Enhanced CT showed no intestinal necrosis. Anticoagulant therapy was started and the thrombosis had almost resolved 40 days later. However, after starting oral intake, the patient developed vomiting. Small bowel radiographs and 3D-CT showed significant proximal intestinal stenosis. Small bowel resection was performed on the 59th day after transfer. The pathological diagnosis was ischemic enteritis with venous thrombosis. The patient was discharged 20 days after intestinal resection and he has had no recurrence of symptoms. In this case, 3D-CT was useful to determine the range of intestinal stenosis and the required area of resection.
MISC
243-
日本消化管学会雑誌 2(Suppl.) 73-73 2018年2月
-
臨床外科 72(8) 986-989 2017年8月
-
胆膵の病態生理 33(1) 43-46 2017年6月膵頭十二指腸切除術(PD)を施行し術後胆管炎に、ダブルバルーン内視鏡逆行性胆道造影(DBERC)を施行した13例34回を対象とした。PDを施行した244例中20例(8.2%)に術後胆管炎を認め、反復する胆管炎症例も7例存在し、延べ合計47件の術後胆管炎を認めた。胆管狭窄を伴うものは11例で、吻合部再発をきたしたものは2例、術後胆管炎による死亡例は認めなかった。DBERCは13例、合計34件の術後胆管炎に実施し、肝門部へ到達できなかったのは1件のみで、97%の到達率であった。この1例は、後日再度DBERCを施行した際には到達できた。到達できた際には、造影やステント留置などの胆管内治療も全件において成功した。DBERC関連合併症による胆管炎の悪化や死亡例を認めなかった。
-
胆と膵 38(2) 195-199 2017年2月近年、内視鏡的治療の進歩により、慢性膵炎およびその合併症(膵石症、膵仮性嚢胞、internal pancreatic fistula(IPF:膵性胸腹水)、胆道狭窄)に対して、膵管ステント留置、経胃的ドレナージなどの難易度の高い内視鏡手技が開発され、その低侵襲性から多くの病態では第一選択の治療となっている。しかし、すべての例で内視鏡的治療が実施できる訳ではなく、奏効率、長期成績では外科的治療に劣る部分もあり、どのようなタイミングで外科的治療を行うかを常に念頭に置いて治療計画を検討することが重要である。治療コンプライアンスの悪い症例などでは外科的治療を第一選択とすることも選択肢として、施設の熟達度を考慮し、十分なインフォームドコンセントを行ったうえで治療法を決定する必要がある。(著者抄録)
-
胆と膵 37(12) 1575-1579 2016年12月慢性膵炎の疼痛治療として、まず内科的治療が行われる。外科的治療は内科的治療無効例に対して適応が検討される。膵管拡張例には膵管ドレナージ術が適応になり、術式としては主にPartington手術とFrey手術が行われる。膵切除術は、膵管拡張がなく病変が頭部もしくは体尾部に限局した症例が適応になるが、術後の膵内分泌機能低下が必発であり、それを上回る利点があると判断された症例に実施すべきである。膵全摘術、腹腔神経叢ブロック、(胸腔鏡下)内臓神経切除術は限られた症例のみが適応となる。慢性膵炎の疼痛治療は、症例により所見、疼痛の状態はさまざまで、慢性膵炎が良性疾患であることも考慮して、治療方針を決定する必要がある。外科的治療の実施にあたっても、断酒・禁煙を中心とする生活指導は重要で、治療コンプライアンスの高い症例に対してのみ治療を行うことが推奨される。(著者抄録)
共同研究・競争的資金等の研究課題
6-
日本学術振興会 科学研究費助成事業 基盤研究(B) 2021年4月 - 2026年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2021年4月 - 2024年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2017年4月 - 2021年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2015年4月 - 2019年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2014年4月 - 2018年3月